Response to Osimertinib in Choroidal Metastases from EGFRmt T790M-Positive Non-Small Cell Lung Adenocarcinoma

J Thorac Oncol. 2017 Oct;12(10):e165-e167. doi: 10.1016/j.jtho.2017.06.001.

Authors

Filippo Gustavo Dall'Olio¹, Celeste Ruatta², Barbara Melotti³, Francesca Sperandi³, Antonio Pasquale Ciardella³, Andrea Ardizzoni²

Affiliations

¹ University of Bologna, Bologna, Italy. Electronic address: filippogdallolio@gmail.com.
² University of Bologna, Bologna, Italy.
³ Sant'Orsola Malpighi Hospital, Bologna, Italy.

PMID: 28939150
DOI: 10.1016/j.jtho.2017.06.001

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acrylamides
Adenocarcinoma / drug therapy*
Adenocarcinoma / pathology
Adenocarcinoma of Lung
Aniline Compounds
Carcinoma, Non-Small-Cell Lung / drug therapy*
Carcinoma, Non-Small-Cell Lung / pathology
ErbB Receptors / metabolism*
Female
Humans
Lung Neoplasms / drug therapy*
Lung Neoplasms / pathology
Middle Aged
Neoplasm Metastasis
Piperazines / pharmacology
Piperazines / therapeutic use*
Protein Kinase Inhibitors / pharmacology
Protein Kinase Inhibitors / therapeutic use*

Substances

Acrylamides
Aniline Compounds
Piperazines
Protein Kinase Inhibitors
osimertinib
ErbB Receptors